XETRA • EUR Eurofins Scientific SE (ESF0.DE) Follow Compare 46.07 -2.75 (-5.63%) At close: 5:28:37 PM GMT+1 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Eurofins Launches Fourth Buy-Back Programme of Its Own Shares LUXEMBOURG, December 20, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF) (the "Company") (EUFI.PA) announces its intention to launch a new buy-back programme of its own shares (ISIN FR0014000MR3) for a maximum amount representing up to 2% of its share capital. This fourth programme follows the first programme that took place between 3 October 2022 and 8 August 2023, the second programme that took place between 25 October 2023 and 30 August 2024, and the third programme that took place Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2024 LUXEMBOURG, December 05, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Sustainability Services Introduces CleanAir Check Service for Volatile Organic Compounds (VOCS) Testing NORTHAMPTON, England, November 25, 2024--Eurofins Sustainability Services, a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a CleanAir Check service that tests for Volatile Organic Compounds (VOCs). Given that VOCs pose significant concerns for human health and the environment, increasingly stringent regulations and heightened pressure on businesses to effectively manage VOCs have emerged. In light of this, Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 October 2024 LUXEMBOURG, November 13, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF): Eurofins Agrees to Acquire SYNLAB’s Clinical Diagnostics Operations in Spain LUXEMBOURG, October 28, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Announces Results of Cash Audit Confirming Its FY 2023 Cash Balance and the High Integrity of Its Systems and Controls and Refutes Muddy Waters’ Allegations Regarding Transactions That Occurred Between 10 and 25 Years Ago LUXEMBOURG, October 22, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Confirms Profitability and Cash Flow Objectives for 2024 Leading to Higher Profit Margins in Spite of the Impact of the Post-COVID Reset of BioPharma Pipelines LUXEMBOURG, October 22, 2024--Regulatory News: Eurofins’ (Paris:ERF) organic growth momentum remained robust in Q3 in most business lines: Eurofins: Purchases of Own Shares from October 14th to October 18th, 2024 LUXEMBOURG, October 21, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins: Purchases of Own Shares From October 7th to October 11th, 2024 LUXEMBOURG, October 14, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Discovery Extends AI-powered Integrated Drug Discovery Collaboration SAN DIEGO, October 10, 2024--Eurofins Discovery, an industry-leading provider of products and services for drug discovery research, announced today the renewal of its collaboration with Italy-based Dompé farmaceutici S.p.A., which is applying their internal AI platform to accelerate the identification of novel therapeutics. Eurofins: Purchases of Own Shares From September 30th to October 4th, 2024 LUXEMBOURG, October 07, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 September 2024 LUXEMBOURG, October 04, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF): Eurofins: Purchases of Own Shares from September 23th to September 27th, 2024 LUXEMBOURG, September 30, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins CDMO Alphora Inc. Announces Construction of GMP Biologics Manufacturing Facility MISSISSAUGA, Ontario, September 24, 2024--Eurofins CDMO Alphora Inc. announces the construction of a new GMP Biologics manufacturing facility in Mississauga, Ontario, to manufacture monoclonal Antibodies (mAbs) and protein therapies for clinical and commercial applications. Eurofins Sustainability Services Introduces EUDR Deforestation Impact Assessment NORTHAMPTON, United Kingdom, September 24, 2024--Eurofins Sustainability Services (Paris:ERF), a full-service provider for retailers, brands, and manufacturers of consumer products, has grown its extensive service offering to include a deforestation impact assessment. The European Union’s Deforestation Regulation (EUDR) aims to prevent the import and sale of products linked to deforestation in the EU market – covering specific commodities, including cattle, cocoa, coffee, palm oil, soy, wood, an Eurofins: Purchases of Own Shares From September 16th to September 20th, 2024 LUXEMBOURG, September 23, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins Consumer Product Testing Laboratory in Boston Completes Significant Expansion BOSTON, September 19, 2024--Eurofins MTS Consumer Product Testing US, based in Norwood, Boston MA, has completed a significant expansion, doubling total laboratory space, increasing workforce by 30% and adding three new specialised laboratories focused on Softlines & Hardlines, Furniture, and Toys. Eurofins MTS Consumer Product Testing US joined the international network of Eurofins laboratories in 2021 and is a full-service safety, quality, and sustainability service provider for retailers, bra Eurofins: Purchases of Own Shares from September 9th to September 13th, 2024 LUXEMBOURG, September 16, 2024--Regulatory News: Eurofins (Paris:ERF): The Eurofins Network Expands Its BioPharma Product Testing Offering in the United States With the Acquisition of Infinity Laboratories, Inc. LUXEMBOURG, September 16, 2024--Regulatory News: Eurofins (Paris:ERF): Eurofins: Purchases of Own Shares From September 02nd to September 06th, 2024 LUXEMBOURG, September 09, 2024--Regulatory News: Eurofins (Paris:ERF): Performance Overview Trailing total returns as of 1/14/2025, which may include dividends or other distributions. Benchmark is CAC 40 Return ESF0.DE CAC 40 YTD -5.85% +1.51% 1-Year -17.77% -0.56% 3-Year -49.48% +3.09%